R. Kay

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Terry L. Smith, R. Collins, L. Holmberg, 1998, Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Cancer clinical trials : a critical appraisal

M. Baum, R. Kay, H. Scheurlen, 1988 .

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.

M. Zelen, R. Gelber, A. Goldhirsch, 1989, The New England journal of medicine.

Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.

M. Zelen, R. Gelber, B. Gusterson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

On the use of hazard functions in breast cancer studies.

M Schumacher, M. Schumacher, R. Kay, 1982, Experientia. Supplementum.

Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand

R. Kay, B. Mason, RK McNee, 2005, Breast Cancer Research and Treatment.